CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The RETORNA project aims to develop RNA-based therapies for retinal diseases, such as macular degeneration and retinitis pigmentosa. By analyzing RNA profiles in retinal cells and utilizing various research methods, the project seeks to identify therapeutic targets and assess the potential for commercialization.
Today, vision impairment up to total blindness represents an increasing global problem with significant social and economic impact upon affected patients and society as a whole.
Despite the advancing of knowledge on their genetic basis, there is no effective cure for retinal diseases (RD) to date and therefore there is an urgent need to fill this gap.The present DN “Targeting RNA as an approach for treating retinal disease” (RETORNA) aims to treat RD by using RNA therapy.
Among the research obje…
FUNDACION UNIVERSIDAD CATOLICA DE VALENCIA SAN VICENTE MARTIR
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Leipzig
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Alicante
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Türkiye, Istanbul
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
